Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs PIRAMAL ENTERPRISES - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA PIRAMAL ENTERPRISES ABBOTT INDIA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 47.8 -38.7 - View Chart
P/BV x 15.6 1.3 1,197.3% View Chart
Dividend Yield % 0.4 1.8 24.8%  

Financials

 ABBOTT INDIA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
PIRAMAL ENTERPRISES
Mar-19
ABBOTT INDIA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs8,8343,303 267.5%   
Low Rs5,4581,797 303.7%   
Sales per share (Unadj.) Rs1,731.1716.5 241.6%  
Earnings per share (Unadj.) Rs211.979.7 265.9%  
Cash flow per share (Unadj.) Rs219.9107.9 203.8%  
Dividends per share (Unadj.) Rs65.0028.00 232.1%  
Dividend yield (eoy) %0.91.1 82.8%  
Book value per share (Unadj.) Rs945.21,477.5 64.0%  
Shares outstanding (eoy) m21.25184.45 11.5%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x4.13.6 116.0%   
Avg P/E ratio x33.732.0 105.4%  
P/CF ratio (eoy) x32.523.6 137.5%  
Price / Book Value ratio x7.61.7 438.1%  
Dividend payout %30.735.1 87.3%   
Avg Mkt Cap Rs m151,848470,292 32.3%   
No. of employees `0003.57.8 44.6%   
Total wages/salary Rs m4,35622,504 19.4%   
Avg. sales/employee Rs Th10,555.516,899.4 62.5%   
Avg. wages/employee Rs Th1,249.92,877.7 43.4%   
Avg. net profit/employee Rs Th1,292.21,879.9 68.7%   
INCOME DATA
Net Sales Rs m36,786132,153 27.8%  
Other income Rs m1,1333,128 36.2%   
Total revenues Rs m37,919135,281 28.0%   
Gross profit Rs m6,04766,290 9.1%  
Depreciation Rs m1695,202 3.3%   
Interest Rs m2344,097 0.1%   
Profit before tax Rs m6,98920,119 34.7%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4858,611 28.9%   
Profit after tax Rs m4,50314,701 30.6%  
Gross profit margin %16.450.2 32.8%  
Effective tax rate %35.642.8 83.1%   
Net profit margin %12.211.1 110.0%  
BALANCE SHEET DATA
Current assets Rs m27,610122,742 22.5%   
Current liabilities Rs m8,569310,810 2.8%   
Net working cap to sales %51.8-142.3 -36.4%  
Current ratio x3.20.4 815.9%  
Inventory Days Days6023 261.0%  
Debtors Days Days2739 70.5%  
Net fixed assets Rs m1,057116,904 0.9%   
Share capital Rs m213369 57.6%   
"Free" reserves Rs m19,873272,161 7.3%   
Net worth Rs m20,086272,530 7.4%   
Long term debt Rs m0270,196 0.0%   
Total assets Rs m29,409856,261 3.4%  
Interest coverage x311.61.5 21,397.7%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x1.30.2 810.5%   
Return on assets %15.46.9 224.1%  
Return on equity %22.45.4 415.6%  
Return on capital %34.912.4 281.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36915,200 2.4%   
Fx outflow Rs m4,9184,889 100.6%   
Net fx Rs m-4,54910,312 -44.1%   
CASH FLOW
From Operations Rs m4,991-115,975 -4.3%  
From Investments Rs m-2,570-8,265 31.1%  
From Financial Activity Rs m-1,428107,525 -1.3%  
Net Cashflow Rs m993-16,650 -6.0%  

Share Holding

Indian Promoters % 0.0 52.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 4.0 197.5%  
FIIs % 0.1 26.6 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 16.5 103.6%  
Shareholders   18,270 93,274 19.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   FULFORD INDIA  VENUS REMEDIES  CIPLA  WOCKHARDT  AUROBINDO PHARMA  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 300 Points Lower; Dow Futures Down by 31 Points(12:30 pm)

Share markets in India are presently trading on a negative note. The BSE Sensex is trading down by 390 points, down 0.8% at 48,644 levels.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY21); Net Profit Up 22.1% (Quarterly Result Update)

Aug 25, 2020 | Updated on Aug 25, 2020

For the quarter ended June 2020, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 22.1% YoY). Sales on the other hand came in at Rs 29 bn (down 16.2% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 18, 2021 03:36 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - ASTRAZENECA PHARMA COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS